Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PCsReasy / Re: Here's a quick thought
2
Oct 24, 2007 10:19AM
$5/shr is the equivalent to $2B market cap. At a P/E of 39, that would mean $50M per year in earnings, possible, but hard to predict/rely on without a more stable income model, IMO. Financing the M/A deals will likely require more shares or outside financing which will be adverse at share prices sub $2, so I think the share price needs to be higher BEFORE M/A activity. I hope those who think $4 is possible on settlement/ruling and license fees alone are correct. If so, that will be great.
4
Oct 24, 2007 10:51PM
3
Oct 24, 2007 11:11PM
3
Oct 25, 2007 02:43PM
Share
New Message
Please login to post a reply